Lipoprotein(a) and ASCVD Risk

Dr. Marlys Koschinsky describes Lipoprotein(a) and the increased risk for ASCVD.

Member Cost: $0Non-member Cost: $0
Credits: 0 CE contact hours, 0 CE pharmacology hours

Course Overview

Dr. Marlys Koschinsky describes Lipoprotein(a) and the increased risk for atherosclerotic cardiovascular disease (ASCVD). Join Dr. Koschinsky as she discusses measurement practices, the genetic link to Lipoprotein(a), and future treatment opportunities. This course also takes learners through a case study to explain elevated Lipoprotein(a) risk and initial diagnosis. 

Member Cost: $0Non-member Cost: $0
Credits: 0 CE contact hours, 0 CE pharmacology hours

Register

Learning Objectives

  1. Describe Lipoprotein(a) and measurement practices  
  1. Explore the link between Lipoprotein(a), ASCVD risk, and family history    
  1. Discuss current and future treatments for Lipoprotein(a)    
  1. Review a case study on the explanation of elevated Lipoprotein(a) risk and initial diagnosis 

Faculty

  • Marlys Koschinsky PhD, FAHA, FNLA, FCAHS, FACC, OOnt
Full_Color_Provider

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of PCNA. PCNA is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 030602.